Stay updated on Ipilimumab Plus Talimogene Laherparepvec Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.
Latest updates to the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page
- CheckyesterdayChange DetectedDeleted the study topic 'Melanoma' and the related topic 'MedlinePlus Genetics' from the page's related topics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page footer revision tag updated from v3.2.0 to v3.3.2. No study data or core functionality appears to be affected.SummaryDifference0.0%
- Check30 days agoChange DetectedAdded related topics Melanoma and MedlinePlus Genetics to the page, and removed the government funding status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check37 days agoChange DetectedThe Melanoma topic and the MedlinePlus Genetics related topics were removed from the page's related topics section.SummaryDifference0.1%
- Check52 days agoChange DetectedNo substantive changes detected between the two screenshots; the page still presents the Study Details for NCT01740297 with the same sections (Overview, Eligibility Criteria, Plan, Contacts and Locations).SummaryDifference0.3%
- Check66 days agoChange DetectedRemoved the MedlinePlus Genetics topic Melanoma from the page, reducing the page’s coverage of genetic topics related to melanoma.SummaryDifference0.1%
Stay in the know with updates to Ipilimumab Plus Talimogene Laherparepvec Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.